510 related articles for article (PubMed ID: 34576340)
1. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
Costantini S; Capone F; Polo A; Bagnara P; Budillon A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
[TBL] [Abstract][Full Text] [Related]
2. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
[TBL] [Abstract][Full Text] [Related]
3. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism.
Bruderer RM; Brasseur C; Meyer HH
J Biol Chem; 2004 Nov; 279(48):49609-16. PubMed ID: 15371428
[TBL] [Abstract][Full Text] [Related]
4. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
[TBL] [Abstract][Full Text] [Related]
5. The UBX domain in UBXD1 organizes ubiquitin binding at the C-terminus of the VCP/p97 AAA-ATPase.
Blueggel M; Kroening A; Kracht M; van den Boom J; Dabisch M; Goehring A; Kaschani F; Kaiser M; Bayer P; Meyer H; Beuck C
Nat Commun; 2023 Jun; 14(1):3258. PubMed ID: 37277335
[TBL] [Abstract][Full Text] [Related]
6. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
Ballar P; Shen Y; Yang H; Fang S
J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
[TBL] [Abstract][Full Text] [Related]
7. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
8. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.
Hänzelmann P; Schindelin H
J Biol Chem; 2011 Nov; 286(44):38679-38690. PubMed ID: 21914798
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).
Kim SJ; Cho J; Song EJ; Kim SJ; Kim HM; Lee KE; Suh SW; Kim EE
J Biol Chem; 2014 May; 289(18):12264-74. PubMed ID: 24610782
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ER-associated degradation via p97/VCP-interacting motif.
Ballar P; Fang S
Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
[TBL] [Abstract][Full Text] [Related]
11. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
12. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD).
Lee JJ; Park JK; Jeong J; Jeon H; Yoon JB; Kim EE; Lee KJ
J Biol Chem; 2013 Mar; 288(10):6998-7011. PubMed ID: 23293021
[TBL] [Abstract][Full Text] [Related]
13. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
14. Expanding into new markets--VCP/p97 in endocytosis and autophagy.
Bug M; Meyer H
J Struct Biol; 2012 Aug; 179(2):78-82. PubMed ID: 22450227
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
[TBL] [Abstract][Full Text] [Related]
16. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
[TBL] [Abstract][Full Text] [Related]
18. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
[TBL] [Abstract][Full Text] [Related]
19. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
Kobayashi T; Tanaka K; Inoue K; Kakizuka A
J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
